Skip to main content

Advertisement

SpringerLink
Log in

Screening for depressive symptoms in patients with unresectable lung cancer

  • Short Communication
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Introduction

Early identification of psychological distress and depression is important to optimise the quality of life in patients with advanced non-small cell lung cancer (NSCLC). The prevalence of depression may vary, depending on the time since diagnosis of cancer, results of the treatment and the prognosis. The purpose of this study was to compare the efficacy of a self-administered screening tool (Hospital Anxiety and Depression Scale (HADS)) with a health professional administered tool (Montgomery–Asberg Depression Rating Scale (MADRS)) and to explore the variability of major affective symptoms in patients with unresectable lung cancer during the initial 7–8 weeks of chemotherapy treatment for their illness.

Material and methods

Patients with newly diagnosed unresectable lung cancer were screened on four occasions for anxiety and depressive symptoms simultaneously using the self-rated HADS and the MADRS administered by a psycho-oncologist or a trained research associate. The first assessment was done within 1 week of diagnosis and was repeated on 3 occasions during the initial 2 cycles of chemotherapy.

Results

Forty-nine patients, aged 38–82 years (median age 63 years) were enrolled. All patients had advanced NSCLC (stages 3A, 3B and 4) and 61% (30 patients) had an ECOG performance status (PS) of 1 or greater. The point prevalence of depression measured by an interviewer using the MADRS at visits 1–4 was 49%, 51%, 47%, and 41%, respectively. The point prevalence of self-reported depression (HADS) was significantly (p < 0.001) lower at each assessment point (18%, 20%, 6%, 12%) compared to health professional detected depression (MADRS). Although MADRS and HADS showed very strong (Pearson’s correlation = 0.8) and significant (p < 0.001) correlation, the concordance rate in identifying the same cases of depression was only 54%.

Clinical implication and conclusion

The prevalence of depression among advanced lung cancer patients is high and varies very little during the first 2 cycles of chemotherapy. Among a variety of tools available for the screening of depression, a semi-structured interview is more effective at identifying clinically significant depression than a self-administered questionnaire.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Adkins B, Titus-Howard T, Massey V et al (2005) Recognizing depression in cancer outpatients. Community Oncology 2:528–533

    Google Scholar 

  2. Akechi T, Okuyama T, Akizuki N et al (2006) Course of psychological distress and its predictors in advanced non-small cell lung cancer patients. Psychooncology 15:463–473

    Article  PubMed  Google Scholar 

  3. Ballenger JC, Davidson JR, Lecrubier Y et al (2001) Consensus statement on depression, anxiety and oncology. J Clin Psychiatry 62:64–67

    PubMed  Google Scholar 

  4. Berard RMF, Boermeester F, Viljoen G (1998) Depressive disorders in an out-patient oncology setting: prevalence, assessment, and management. Psychooncology 7:112–120

    Article  PubMed  CAS  Google Scholar 

  5. Bjelland I, Dahl AA, Haug TT et al (2002) The validity of the hospital anxiety and depression scale. An updated literature review. J Psychosom Res 52:69–77

    Article  PubMed  Google Scholar 

  6. Block SD (2000) Assessing and managing depression in the terminally ill patient. ACP-ASIM End-of-Life Care Consensus Panel. American College of Physicians-American Society of Internal Medicine. Ann Intern Med 132:209–218

    PubMed  CAS  Google Scholar 

  7. Carlsen K, Jensen AB, Jacobsen E et al (2005) Psychosocial aspects of lung cancer. Lung Cancer 47:293–300

    Article  PubMed  Google Scholar 

  8. Carroll BT, Kathol RG, Noyes R Jr et al (1993) Screening for depression and anxiety in cancer patients using the Hospital Anxiety and Depression Scale. Gen Hosp Psychiatry 15:69–74

    Article  PubMed  CAS  Google Scholar 

  9. Chochinov HM (2001) Depression in cancer patients. Lancet Oncol 2:499–505

    Article  PubMed  CAS  Google Scholar 

  10. Donaldson G, Moinpour CM (2005) Learning to live with missing quality-of-life data in advanced-stage disease trials. J Clin Oncol 23:7380–7384

    Article  PubMed  Google Scholar 

  11. Derogatis LR, Morrow GR, Fetting J et al (1983) The prevalence of psychiatric disorders among cancer patients. JAMA 249:751–757

    Article  PubMed  CAS  Google Scholar 

  12. Hall A, A’Hern R, Fallowfield L (1999) Are we using appropriate self-report questionnaires for detecting anxiety and depression in women with early breast cancer? Eur J Cancer 35:79–85

    Article  PubMed  CAS  Google Scholar 

  13. Hopwood P, Stephens RJ (2000) Depression in patients with lung cancer: prevalence and risk factors derived from quality-of-life data. J Clin Oncol 18:893–908

    PubMed  CAS  Google Scholar 

  14. Hotopf M, Chidgey J, Addington-Hall J et al (2002) Depression in advanced disease: a systematic review Part 1. Prevalence and case finding. Palliat Med 16:81–97

    Article  PubMed  CAS  Google Scholar 

  15. Johnston M, Pollard B, Hennessey P (2000) Construct validation of the hospital anxiety and depression scale with clinical population. J Psychosom Res 48:579–584

    Article  PubMed  CAS  Google Scholar 

  16. Kearns NP, Cruickshank CA, McGuigan KJ et al (1982) A comparison of depression rating scales. Br J Psychiatry 141:45–49

    PubMed  CAS  Google Scholar 

  17. Le Fevre P, Devereux J, Smith S (1999) Screening for psychiatric illness in the palliative care inpatient setting: a comparison between the Hospital Anxiety and Depression Scale and the General Health Questionnaire-12. Palliat Med 13:399–407

    Article  PubMed  Google Scholar 

  18. Lloyd-Williams M, Freidman T, Rudd N (2000) Criterion validation of the Edinburgh postnatal depression scale as a screening tool for depression in patients with advanced metastatic cancer. J Pain Symptom Manage 20:259–265

    Article  PubMed  CAS  Google Scholar 

  19. Mazumdar S, Lui KS, Houck PR, Reynolds CF 3rd (1999) Intent-to-treat analysis for longitudinal clinical trials: coping with the challenge of missing values. J Psychiatr Res 33:87–95

    Article  PubMed  CAS  Google Scholar 

  20. McDonald MY, Passik SD, Dugan W (1999) Nurses’ recognition of depression in their patients with cancer. Oncol Nurs Forum 26:593–599

    PubMed  CAS  Google Scholar 

  21. Middelboe T, Ovesen L, Mortensen EL et al (1994) Depressive symptoms in cancer patients undergoing chemotherapy: a psychometric analysis. Psychother Psychosom 61:171–177

    Article  PubMed  CAS  Google Scholar 

  22. Montazeri A, Milroy R, Hole D et al (1998) Anxiety and depression in patients with lung cancer before and after diagnosis: findings from a population in Glasgow, Scotland. J Epidemiol Community Health 52:203–204

    PubMed  CAS  Google Scholar 

  23. Montgomery SA, Asberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry 134:382–389

    PubMed  CAS  Google Scholar 

  24. Moorey S, Greer S, Watson M et al (1991) The factor structure and factor stability of the hospital anxiety and depression scale in patients with cancer. Br J Psychiatry 158:255–259

    Article  PubMed  CAS  Google Scholar 

  25. Muller MJ, Himmerich H, Kienzle B et al (2003) Differentiating moderate and severe depression using the Montgomery–Asberg depression rating scale (MADRS). J Affect Disord 77:255–260

    Article  PubMed  Google Scholar 

  26. Mykletun A, Stordal E, Dahl AA (2001) Hospital Anxiety and Depression (HAD) scale: factor structure, item analyses and internal consistency in a large population. Br J Psychiatry 179:540–544

    Article  PubMed  CAS  Google Scholar 

  27. Passik SD, Kirsh KL, Donaghy KB et al (2001) An attempt to employ the Zung Self-Rating Depression Scale as a “lab test” to trigger follow-up in ambulatory oncology clinics: criterion validity and detection. J Pain Symptom Manage 21:273–281

    Article  PubMed  CAS  Google Scholar 

  28. Patrick DL, Ferketich SL, Frame PS et al (2004) National Institute of Health State-of-the-Science Conference Statement: symptom management in cancer: pain, depression, and fatigue, July 15–17, 2002. J Natl Cancer Inst Monogr 32:9–16

    PubMed  Google Scholar 

  29. Schafer JL (1999) Multiple imputation: a primer. Stat Methods Med Res 8:3–15

    Article  PubMed  CAS  Google Scholar 

  30. Sharpe M, Strong V, Allen K et al (2004) Major depression in outpatients attending a regional cancer centre: screening and unmet treatment needs. Br J Cancer 90:314–320

    Article  PubMed  CAS  Google Scholar 

  31. Skarstein J, Aass N, Fossa SD et al (2000) Anxiety and depression in cancer patients: relation between the Hospital Anxiety and Depression Scale and the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire. J Psychosom Res 49:27–34

    Article  PubMed  CAS  Google Scholar 

  32. Snaith RP, Harrop FM, Newby DA et al (1986) Grade scores of the Montgomery–Asberg Depression and Clinical Anxiety Scales. Br J Psychiatry 148:599–601

    Article  PubMed  CAS  Google Scholar 

  33. Snaith RP, Taylor CM (1985) Rating scales for depression and anxiety: a current perspective. Br J Clin Pharmacol 19:175–200

    Google Scholar 

  34. Littell RC, Milliken GA, Stroup WW et al (2006) SAS for mixed models, 2nd edn. SAS Institute, Cary, NC, USA

    Google Scholar 

  35. Trask PC (2004) Assessment of depression in cancer patients. J Natl Cancer Inst Monogr 32:80–92

    Article  PubMed  Google Scholar 

  36. Uchitomi Y, Mikati I, Kugaya A et al (2000) Depression after successful treatment for nonsmall cell lung cancer. Cancer 89:1172–1179

    Article  PubMed  CAS  Google Scholar 

  37. Yung YC (2000) Multiple imputations for missing data: concepts and new development. SUGI Paper. SAS Institute, Cary, NC, USA, pp 267–325

    Google Scholar 

  38. Zabora J, BrintzenhofeSzoc K, Curbow B et al (2001) The prevalence of psychological distress by cancer site. Psychooncology 1:19–28

    Article  Google Scholar 

  39. Zimmerman M, Chelminski I, Pasternak M (2004) A review of studies of the Montgomery–Asberg Depression Rating Scale in controls: implications for the definition of remission in treatment studies of depression. Int Clin Psychopharmacol 19:1–7

    Article  PubMed  Google Scholar 

  40. Zimmerman M, Posternak MA, Chelminski I (2004) Derivation of a definition of remission on the Montgomery–Asberg depression rating scale corresponding to the definition of remission on the Hamilton rating scale for depression. J Psychiatr Res 38:577–582

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Psychology, Department of Psychiatry, Jewish General Hospital, 3755 Cote St Catherine Rd, Montreal, H3T 1E2, Canada

    S. Néron

  2. Pulmonary Division, Department of Medicine, Jewish General Hospital, 3755 Cote St Catherine Rd, Montreal, H3T 1E2, Canada

    S. Néron, E. Dajczman, G. Kasymjanova, H. Kreisman & D. Small

  3. Pulmonary Division, Department of Nursing, Jewish General Hospital, 3755 Cote St Catherine Rd, Montreal, H3T 1E2, Canada

    E. Dajczman

  4. Department of Mathematics and Statistics, McGill University, Montreal, Canada

    J. A. Correa

Authors
  1. S. Néron
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. A. Correa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E. Dajczman
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G. Kasymjanova
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. H. Kreisman
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. D. Small
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to G. Kasymjanova.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Néron, S., Correa, J.A., Dajczman, E. et al. Screening for depressive symptoms in patients with unresectable lung cancer. Support Care Cancer 15, 1207–1212 (2007). https://doi.org/10.1007/s00520-007-0225-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-007-0225-z

Keywords

Search

Navigation